ABOUT
About MakingLife
About MakingPharmaindustry
Contact us
PUBBLICATIONS
MakingPharmaIndustry
RESEARCH
Clinical research
Technology
MANUFACTURING
BioDrugs & ATMP
Contract manufacturing
GMP
Production lines & equipments
API & Excipients
Packaging
Quality & Validation
PHARMA ENGINEERING by ISPE
Technology
SUPPLEMENTS
REGULATORY
Guidelines
Legislation
Pharmacovigilance
SUPPLY CHAIN
Blockchain
GDP
Artificial intelligence
Logistics
Management
Security and privacy
DIGITAL HEALTH
Medical devices
Telemedicine
Digital Therapies
BUSINESS
EVENTS
Corporate Social Responsibility
Deal & Finance
Digital transformation
Diversity & Inclusion
ESG
Insights
Leadership changes
Leadership lessons
Marketing & Communication
Market
Human resources
Startup
EIPG NEWS
Search
Search
ABOUT
About MakingLife
About MakingPharmaindustry
Contact us
PUBBLICATIONS
MakingPharmaIndustry
RESEARCH
Clinical research
Technology
MANUFACTURING
BioDrugs & ATMP
Contract manufacturing
GMP
Production lines & equipments
API & Excipients
Packaging
Quality & Validation
PHARMA ENGINEERING by ISPE
Technology
SUPPLEMENTS
REGULATORY
Guidelines
Legislation
Pharmacovigilance
SUPPLY CHAIN
Blockchain
GDP
Artificial intelligence
Logistics
Management
Security and privacy
DIGITAL HEALTH
Medical devices
Telemedicine
Digital Therapies
BUSINESS
EVENTS
Corporate Social Responsibility
Deal & Finance
Digital transformation
Diversity & Inclusion
ESG
Insights
Leadership changes
Leadership lessons
Marketing & Communication
Market
Human resources
Startup
EIPG NEWS
Home
Authors
Posts by Simone Montonati
Simone Montonati
153 POSTS
0 COMMENTS
API & Excipients
Life science raw ingredients: will 2024 be the year of recovery?
Simone Montonati
-
December 26, 2023
0
ESG
European packaging regulation: ‘single market at risk’ according to associations
Simone Montonati
-
December 26, 2023
0
Market
The rules of attraction (for assets)
Simone Montonati
-
November 9, 2023
0
Deal & Finance
Roche takes aim at inflammatory bowel disease
Simone Montonati
-
November 5, 2023
0
Deal & Finance
Sanofi’s strategic turnaround
Simone Montonati
-
October 29, 2023
0
Deal & Finance
Goodbye NASH, it’s Alfasigma’s time
Simone Montonati
-
October 17, 2023
0
Market
APIs between market opportunities and geopolitical risks
Simone Montonati
-
October 4, 2023
0
Market
Biosimilars, a 1.6 billion euro saving
Simone Montonati
-
September 21, 2023
0
Corporate Social Responsibility
The pharma green revolution (still missing)
Simone Montonati
-
September 15, 2023
0
1
...
4
5
6
Page 5 of 6